<DOC>
	<DOCNO>NCT00344825</DOCNO>
	<brief_summary>300 patient , start new pharmacological treatment B-CLL , enrol 36 Italian Centres assess Quality Life ( QoL ) . A descriptive analysis QoL correlation age , sex , stage disease , Time first B-CLL diagnosis , Number previous B-CLL treatment , reason start new B-CLL treatment : therapeutic Regimen , type Centre , B-CLL treatment lasting , response B-CLL treatment .</brief_summary>
	<brief_title>Vitalis Study - Observational Study Quality Life Patients Under Treatment B-Chronic Lymphocytic Leukemia ( B-CLL )</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Leukemia , B-Cell</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Alemtuzumab</mesh_term>
	<criteria>Aged &gt; /=18 year Patients either sex BCLL , start new pharmacological treatment BChronic Lymphocytic Leukemia ( 1st , 2nd , 3rd , 4th ) Foreseen duration CLL therapy &lt; /= 6 month BChronic Lymphocytic Leukemia progressive stage A , stage B C ( accord Binet system ) , IIIV ( accord Rai system ) WHO Performance Status &lt; /= 2 Life expectancy &lt; /= 6 month Signed Informed consent personal data 's treatment availability fill QoL questionnaire Patients tumour disease Chronic Lymphocytic Leukemia therapy last 30 day V0 More 3 previous CLL treatment ( therapy define drug and/or treatment period ) Previous stem cell transplantation Concurrent last 30 day participation clinical trial Any medical psychological condition might compromise capacity sign consent personal data 's treatment fill QoL questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>B- Chronic Lymphocytic Leukemia</keyword>
</DOC>